| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00188045 Details | 2017-11-01 Interventional | 4 | - | Propranolol Spironolactone Fibrosis Liver Cirrhosis… Alcoholic Cirrh… | - - | |||
| NCT02728245 Details | 2017-10-31 Interventional | 2 | 0 | Dienogest Endometriosis Ovarian Reserve | Placebo cannot be prepared - | |||
| NCT00853944 Details | 2017-10-30 Interventional | 3 | - | Dipeptidyl-Pept… Sitagliptin Pho… Islet Transplan… | Sponsor withdrew funding du to lack of enrollment. Lack of enrollment was due to decrease in
number of islet transplant procedures - | |||
| NCT00564460 NCT00547430 Details | 2017-10-30 Interventional | 3 | 0 | Finasteride Hyperplasia Prostatic Hyper… Benign Prostati… | Change of practice pattern. Green light laser - | |||
| NCT02302092 Details | 2017-10-27 Interventional | 3 | 13 | Cefepime Communicable Di… Infections Urinary Tract I… Urinary Tract I… | Study was prematurely terminated due to administrative and strategic reasons The study is limited as only 13 out of the original 80 participants planned entered the study, due to this none of the planned statistical analyses from the protocol could be carried out, and all results should be reviewed with caution. | |||
| NCT02108951 Details | 2017-10-27 Interventional | 3 | 20 | Nilotinib Leukemia Leukemia, Myelo… Leukemia, Myelo… Philidelphia Po… | Study was terminated because of slow recruitment The study was planned to enroll 130 patients. Study got terminated with 20 patients because of slow recruitment. Therefore, due to small sample size, the results cannot be considered clinical significant. | |||
| NCT02802995 Details | 2017-10-26 Interventional | 3 | [1 Refs] | 15 | Thrombin Varicose Ulcer Stasis Ulcer | Resource issue - | ||
| NCT02496975 Details | 2017-10-26 Interventional | 1/2 | 0 | Cyclosporine Cyclosporins Brain Injuries Brain Injuries,… Wounds and Inju… Traumatic Brain… | Recent studies suggest that cyclosporine A has a very sharp biphasic dose-response problem that
is going to make further clinical translation difficult. - | |||
| NCT00964288 Details | 2017-10-26 Interventional | 1 | 16 | Lidocaine Hyperalgesia Neuralgia Neuropathic Pai… Pain, Neuropath… | During treatment session 3, a subject had a pattern of AEs of severe intensity, suggestive of
brainstem toxicity/encephalopathy during lidocaine/saline infusion - | |||
| NCT02076243 Details | 2017-10-25 Interventional | 2 | 2 | Paclitaxel Carcinoma Carcinoma, Squa… Cutaneous Squam… | Closed by sponsor - | |||
| NCT00672204 Details | 2017-10-25 Interventional | 1/2 | 23 | Antilymphocyte … Sirolimus Thymoglobulin Diabetes Mellit… Diabetes Mellit… Hypoglycemia Type 1 Diabetes… | Raptiva was withdrawn from the market Early termination due to Raptiva being withdrawn from market | |||
| NCT03042325 Details | 2017-10-20 Interventional | 4 | 0 | Alogliptin Diabetes Mellit… Diabetes Mellit… | Business decision, no safety or efficacy concerns - | |||
| NCT02977611 Details | 2017-10-18 Interventional | 2 | 0 | Ferric Oxide, S… Iron Deficienci… Iron Deficiency | FDA Clinical Hold - | |||
| NCT02150473 2013-004604-19 Details | 2017-10-18 Interventional | 3 | 21 | Adalimumab Arthritis Arthritis, Rheu… Rheumatoid Arth… | - - | |||
| NCT02090296 Details | 2017-10-18 Interventional | 2 | 0 | Hydroxyurea Anemia Anemia, Sickle … Sickle Cell Ane… | Participant withdrew consent - | |||
| NCT02032134 Details | 2017-10-18 Interventional | 4 | 5 | Dimethyl Sulfox… Thrombocytopeni… Primary Thrombo… Thrombocytopeni… | recruitment failure within the interval of available CRY BC-PLTs for the study - | |||
| NCT01512199 Details | 2017-10-18 Interventional | 1/2 | 29 | Albumin-Bound P… Antibodies, Mon… Paclitaxel Trastuzumab Breast Neoplasm… Metastatic Brea… | Improved, different standard of care caused business decision to terminate - | |||
| NCT03311178 Details | 2017-10-17 Interventional | 1/2 | 15 | Dobutamine Shock | Substudy 001B is not required at this stage of the PIP - | |||
| NCT01602016 Details | 2017-10-17 Interventional | 2 | 99 | Folic Acid Leucovorin Levoleucovorin Asperger Syndro… Autism Spectrum… Autistic Disord… Child Developme… Asperger's Synd… Autism Pervasive Devel… | Non-compliance - | |||
| NCT00855413 Details | 2017-10-17 Interventional | 4 | 15 | Darunavir Etravirine Ritonavir Acquired Immuno… Communicable Di… HIV Infections Infections Viremia Acute HIV Infec… | Study halted by sponsor due to slow enrollment. Early termination prior to target enrollment due to slow enrollment limited analysis involving optional procedures. Lack of paired (baseline and followup) samples from optional procedures also limited ability to perform these analyses. |